Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.
Lee JE, Kang YW, Jung KH, Son MK, Shin SM, Kim JS, Kim SJ, Fang Z, Yan HH, Park JH, Yoon YC, Han B, Cheon MJ, Woo MG, Seo MS, Lim JH, Kim YS, Hong SS.
Lee JE, et al. Among authors: hong ss.
Cancer Lett. 2021 Jun 1;507:97-111. doi: 10.1016/j.canlet.2021.03.015. Epub 2021 Mar 17.
Cancer Lett. 2021.
PMID: 33744388